Sign In
Buy CG
$42.24
-2.25 (-5.06%)
At Close: Jun 03, 2026
Carlyle to buy 20% stake in Piramal Pharma in $2.8 billion deal
04:15am, Sunday, 28'th Jun 2020
The transaction, which is one of the largest private equity deals in the Indian pharmaceutical industry, values the pharma business at an enterprise value of $2.8 billion and will have an upside compo
Carlyle Group to buy 20% stake in Piramal Pharma for about Rs 3,700 cr
07:01pm, Saturday, 27'th Jun 2020
The transaction values the pharma business at an enterprise value (EV) of $2.77 billion, with an upside component of up to $360 million depending on the company’s FY21 performance.
कार्लाइल ग्रुप पीरामल फार्मा में करेगा 3,700 करोड़ रु का निवेश, खरीदेगा 20 फीसदी हिस्सेदारी
04:41pm, Saturday, 27'th Jun 2020Carlyle Group to buy 20 pc stake in Piramal Pharma for over Rs 3,700 cr
04:41pm, Saturday, 27'th Jun 2020
The capital raise will accelerate Piramal Pharma's organic and inorganic growth plans, the Ajay Piramal-led Piramal Enterprises and Carlyle Group said in the joint statement.
Carlyle Group to buy 20 pc stake in Piramal Pharma for over Rs 3,700 cr
10:45am, Saturday, 27'th Jun 2020Carlyle picks up 20% stake in Piramal pharma biz for $490 mn
09:58am, Saturday, 27'th Jun 2020
The 20% stake sale values Piramals pharma business at Rs 20,000 crore.
Carlyle Group to buy 20 pc stake in Piramal Pharma for over Rs 3,700 cr
09:57am, Saturday, 27'th Jun 2020
The estimated equity capital investment for Carlyle's 20 per cent stake in Piramal Pharma would amount to around USD 490 million.
US-Based Carlyle Buys 20% Stake In Piramal Enterprises' Pharma Business For Rs 3,700 Crore
09:40am, Saturday, 27'th Jun 2020
Piramal Pharma will use the capital raised through the dealto accelerate its organic and inorganic growth plans.
Carlyle buys 20% stake in Piramal Pharma businesses
08:13am, Saturday, 27'th Jun 2020
U.S.-based Carlyle Group Inc has agreed to buy a 20% stake in the pharmaceutical unit of Indian conglomerate Piramal Enterprises Ltd for about $490 million, the companies said in a statement on Saturd
Carlyle Group to acquire 20% stake in Piramal’s pharma business for over Rs 3,700 crore
07:24am, Saturday, 27'th Jun 2020
The company said that this fresh growth investment into its Pharma Business will be used as growth capital for the pharma businesses.
Carlyle Group to buy 20% stake in Piramal Pharma for over ₹3,700 crore
06:20am, Saturday, 27'th Jun 2020US-based Carlyle Group to Buy 20% Stake in Piramal Pharma for Over Rs 3,700 Crore
06:03am, Saturday, 27'th Jun 2020
The estimated equity capital investment for Carlyle's 20 per cent stake in Piramal Pharma would amount to around $490 million.
Carlyle to acquire 20% stake in Piramal's pharma business for ₹3,700 crore
05:37am, Saturday, 27'th Jun 2020
The transaction values the pharma business at an enterprise value of $2.78 billion, with an upside component of up to $360 million depending on the company’s FY21 performance
Carlyle buys 20% stake in Piramal Pharma businesses
05:29am, Saturday, 27'th Jun 2020
U.S.-based Carlyle Group Inc has agreed to buy a 20% stake in the pharmaceutical unit of Indian conglomerate Piramal Enterprises Ltd for about $490 million, the companies said in a statement on Saturd
